• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从分子动力学模拟和量子化学计算看跨膜 G 蛋白偶联受体变构位点的分子间相互作用。

Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface from Molecular Dynamics Simulations and Quantum Chemical Calculations.

机构信息

School of Pharmacy, Medical Biology Centre, Queen's University Belfast, Belfast, Northern IrelandBT9 7BL, U.K.

出版信息

J Chem Inf Model. 2022 Oct 10;62(19):4736-4747. doi: 10.1021/acs.jcim.2c00788. Epub 2022 Sep 30.

DOI:10.1021/acs.jcim.2c00788
PMID:36178787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9554917/
Abstract

Allosteric modulators are called promising candidates in G protein-coupled receptor (GPCR) drug development by displaying subtype selectivity and more specific receptor modulation. Among the allosteric sites known to date, cavities at the receptor-lipid interface represent an uncharacteristic binding location that raises many questions about the ligand interactions and stability, the binding site structure, and how all of these are affected by lipid molecules. In this work, we analyze interactions in the allosteric sites of the PAR2, C5aR1, and GCGR receptors in three lipid compositions using molecular dynamics simulations. In addition, we performed quantum chemical calculations involving the symmetry-adapted perturbation theory (SAPT) and the natural population analysis to quantify the strength of intermolecular interactions. We show that besides classical hydrogen bonds, weak polar interactions such as O-HC, O-Br, and long-range electrostatics with the backbone amides contribute to the stability of allosteric modulators at the receptor-lipid interface. The allosteric cavities are detectable in various membrane compositions. The availability of polar atoms for interactions in such cavities can be assessed by water molecules from simulations. Although ligand-lipid interactions are weak, lipid tails play a role in ligand binding pose stability and the size of allosteric cavities. We discuss physicochemical aspects of ligand binding at the receptor-lipid interface and suggest a compound library enriched by weak donor groups for ligand search in such sites.

摘要

变构调节剂通过显示亚型选择性和更特异性的受体调节,被称为 G 蛋白偶联受体 (GPCR) 药物开发中有前途的候选物。在迄今为止已知的变构位点中,位于受体-脂质界面的腔是一个非典型的结合位置,这引发了许多关于配体相互作用和稳定性、结合位点结构以及所有这些如何受脂质分子影响的问题。在这项工作中,我们使用分子动力学模拟分析了 PAR2、C5aR1 和 GCGR 受体在三种脂质组成中的变构位点的相互作用。此外,我们进行了涉及对称自适应微扰理论 (SAPT) 和自然布居分析的量子化学计算,以量化分子间相互作用的强度。我们表明,除了经典氢键外,弱极性相互作用,如 O-HC、O-Br 和与骨干酰胺的远程静电相互作用,有助于变构调节剂在受体-脂质界面的稳定性。变构腔在各种膜组成中都可检测到。通过模拟中的水分子可以评估此类腔中用于相互作用的极性原子的可用性。尽管配体-脂质相互作用较弱,但脂质尾巴在配体结合构象稳定性和变构腔的大小方面发挥作用。我们讨论了配体在受体-脂质界面结合的物理化学方面,并建议通过弱供体基团丰富配体搜索的化合物库,以在这些位点中进行搜索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c8/9554917/d63752468c5a/ci2c00788_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c8/9554917/6341f7d510af/ci2c00788_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c8/9554917/6bbc254889e3/ci2c00788_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c8/9554917/d63752468c5a/ci2c00788_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c8/9554917/6341f7d510af/ci2c00788_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c8/9554917/6bbc254889e3/ci2c00788_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0c8/9554917/d63752468c5a/ci2c00788_0004.jpg

相似文献

1
Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface from Molecular Dynamics Simulations and Quantum Chemical Calculations.从分子动力学模拟和量子化学计算看跨膜 G 蛋白偶联受体变构位点的分子间相互作用。
J Chem Inf Model. 2022 Oct 10;62(19):4736-4747. doi: 10.1021/acs.jcim.2c00788. Epub 2022 Sep 30.
2
Dynamical Correlations Reveal Allosteric Sites in G Protein-Coupled Receptors.动态相关揭示 G 蛋白偶联受体中的变构位点。
Int J Mol Sci. 2020 Dec 27;22(1):187. doi: 10.3390/ijms22010187.
3
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs.变构药物调节 G 蛋白偶联受体的结构基础。
Nature. 2013 Nov 14;503(7475):295-9. doi: 10.1038/nature12595. Epub 2013 Oct 13.
4
Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.大麻素受体 2 的负变构调节剂:正构激动剂存在下的蛋白建模、结合位点鉴定和分子动力学模拟。
J Biomol Struct Dyn. 2020 Jan;38(1):32-47. doi: 10.1080/07391102.2019.1567384. Epub 2019 Feb 5.
5
The Role of Lipids in Allosteric Modulation of Dopamine D Receptor-In Silico Study.脂质在多巴胺 D 受体变构调节中的作用——计算机模拟研究。
Molecules. 2022 Feb 16;27(4):1335. doi: 10.3390/molecules27041335.
6
Allosteric Modulators of the Class A G Protein Coupled Receptors.A类G蛋白偶联受体的变构调节剂
Adv Exp Med Biol. 2016;917:185-207. doi: 10.1007/978-3-319-32805-8_9.
7
Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.G 蛋白偶联受体的小分子变构调节剂:药物-靶标相互作用。
J Med Chem. 2019 Jan 10;62(1):24-45. doi: 10.1021/acs.jmedchem.7b01844. Epub 2018 Feb 26.
8
Allostery in G protein-coupled receptors investigated by molecular dynamics simulations.变构在 G 蛋白偶联受体中的研究进展:分子动力学模拟。
Curr Opin Struct Biol. 2019 Apr;55:121-128. doi: 10.1016/j.sbi.2019.03.016. Epub 2019 May 13.
9
Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.疏水性和氢键相互作用对 G 蛋白偶联胰高血糖素受体抑制剂 β-丙氨酸类似物活性的影响。
Proteins. 2020 Feb;88(2):327-344. doi: 10.1002/prot.25807. Epub 2019 Sep 10.
10
Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs.膜脂是 GPCR 跨膜变构位点的组成部分:以大麻素 CB1 受体与负变构调节剂 ORG27569 及其类似物结合为例。
J Med Chem. 2022 Sep 22;65(18):12240-12255. doi: 10.1021/acs.jmedchem.2c00946. Epub 2022 Sep 6.

引用本文的文献

1
Allosteric modulation and biased signalling at free fatty acid receptor 2.游离脂肪酸受体2的变构调节与偏向性信号传导
Nature. 2025 Jun 18. doi: 10.1038/s41586-025-09186-6.
2
Comparative Study of Allosteric GPCR Binding Sites and Their Ligandability Potential.变构 GPCR 结合位点及其配体结合潜力的比较研究。
J Chem Inf Model. 2024 Nov 11;64(21):8176-8192. doi: 10.1021/acs.jcim.4c00819. Epub 2024 Oct 23.
3
Novel Autotaxin Inhibitor ATX-1d Significantly Enhances Potency of Paclitaxel-An In Silico and In Vitro Study.新型 Autotaxin 抑制剂 ATX-1d 显著增强紫杉醇的效力:一项计算机模拟和体外研究。

本文引用的文献

1
The pocketome of G-protein-coupled receptors reveals previously untargeted allosteric sites.G 蛋白偶联受体的口袋组学揭示了以前未靶向的变构位点。
Nat Commun. 2022 May 10;13(1):2567. doi: 10.1038/s41467-022-29609-6.
2
Probe Confined Dynamic Mapping for G Protein-Coupled Receptor Allosteric Site Prediction.用于G蛋白偶联受体变构位点预测的探针受限动态映射
ACS Cent Sci. 2021 Nov 24;7(11):1847-1862. doi: 10.1021/acscentsci.1c00802. Epub 2021 Sep 28.
3
Positive allosteric mechanisms of adenosine A receptor-mediated analgesia.腺苷 A 受体介导的镇痛的正变构机制。
Molecules. 2024 Sep 10;29(18):4285. doi: 10.3390/molecules29184285.
4
G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery.G 蛋白偶联受体(GPCRs):结构、机制和药物发现方面的进展。
Signal Transduct Target Ther. 2024 Apr 10;9(1):88. doi: 10.1038/s41392-024-01803-6.
5
Investigating the Unbinding of Muscarinic Antagonists from the Muscarinic 3 Receptor.研究毒蕈碱型乙酰胆碱受体 3 拮抗剂的解结合。
J Chem Theory Comput. 2023 Aug 8;19(15):5260-5272. doi: 10.1021/acs.jctc.3c00023. Epub 2023 Jul 17.
6
Distinct activation mechanisms regulate subtype selectivity of Cannabinoid receptors.不同的激活机制调节大麻素受体的亚型选择性。
Commun Biol. 2023 May 5;6(1):485. doi: 10.1038/s42003-023-04868-1.
7
Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands.别构调节 G 蛋白偶联受体:从分子机制多样性到多个别构结合位点及其配体。
Int J Mol Sci. 2023 Mar 24;24(7):6187. doi: 10.3390/ijms24076187.
8
Study of the Rv1417 and Rv2617c Membrane Proteins and Their Interactions with Nicotine Derivatives as Potential Inhibitors of Erp Virulence-Associated Factor in : An In Silico Approach.运用计算机模拟方法研究 Rv1417 和 Rv2617c 跨膜蛋白及其与尼古丁衍生物的相互作用,作为 Erp 毒力相关因子潜在抑制剂。
Biomolecules. 2023 Jan 28;13(2):248. doi: 10.3390/biom13020248.
Nature. 2021 Sep;597(7877):571-576. doi: 10.1038/s41586-021-03897-2. Epub 2021 Sep 8.
4
Ligand binding at the protein-lipid interface: strategic considerations for drug design.配体在蛋白-脂界面的结合:药物设计的策略考量。
Nat Rev Drug Discov. 2021 Sep;20(9):710-722. doi: 10.1038/s41573-021-00240-2. Epub 2021 Jul 13.
5
Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor.人类D1多巴胺受体的多巴胺结合及变构调节机制
Cell Res. 2021 May;31(5):593-596. doi: 10.1038/s41422-021-00482-0. Epub 2021 Mar 9.
6
Allosteric binding sites at the receptor-lipid bilayer interface: novel targets for GPCR drug discovery.位于受体-脂双层界面的变构结合位点:G 蛋白偶联受体药物发现的新靶标。
Drug Discov Today. 2021 Mar;26(3):690-703. doi: 10.1016/j.drudis.2020.12.001. Epub 2020 Dec 7.
7
The development of proteinase-activated receptor-2 modulators and the challenges involved.蛋白酶激活受体-2 调节剂的研发及面临的挑战。
Biochem Soc Trans. 2020 Dec 18;48(6):2525-2537. doi: 10.1042/BST20200191.
8
Addressing free fatty acid receptor 1 (FFAR1) activation using supervised molecular dynamics.利用监督分子动力学技术解决游离脂肪酸受体 1(FFAR1)的激活问题。
J Comput Aided Mol Des. 2020 Nov;34(11):1181-1193. doi: 10.1007/s10822-020-00338-6. Epub 2020 Aug 27.
9
Structural insights into probe-dependent positive allosterism of the GLP-1 receptor.GLP-1 受体探针依赖性正变构作用的结构见解。
Nat Chem Biol. 2020 Oct;16(10):1105-1110. doi: 10.1038/s41589-020-0589-7. Epub 2020 Jul 20.
10
An allosteric modulator binds to a conformational hub in the β adrenergic receptor.变构调节剂与β肾上腺素受体中的构象枢纽结合。
Nat Chem Biol. 2020 Jul;16(7):749-755. doi: 10.1038/s41589-020-0549-2. Epub 2020 Jun 1.